Pharmaceutical Companies
Zentalis Pharmaceuticals
๐บ๐ธUnited States
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It...
Tenaya Therapeutics
๐บ๐ธUnited States
- Ownership
- Public
- Established
- 2016-01-01
- Employees
- 140
- Market Cap
- $216.1M
Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. It operates through its product platforms: gene therapy, cellular regeneration, and precision medicine....
Macrogenics
๐บ๐ธUnited States
- Ownership
- -
- Established
- -
- Employees
- 339
- Market Cap
- $215.1M
- Website
- -
MacroGenics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of antibody-based therapeutics for the treatment of cancer. Its product pipeline includes Margetuximab, Flotetuzumab, Retifanlimab,...
ATAI Life Sciences AG
๐ฉ๐ชGermany
Codexis
๐บ๐ธUnited States
Trevi Therapeutics
๐บ๐ธUnited States
- Ownership
- Public
- Established
- 2011-01-01
- Employees
- 25
- Market Cap
- $211.2M
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization Haduvio to treat serious neurologically mediated conditions. It includes treatment of chronic pruritus...
Nykode Therapeutics ASA
๐ณ๐ดNorway
Gossamer Bio
๐บ๐ธUnited States
Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of...
Inhibrx Biosciences
๐บ๐ธUnited States
- Ownership
- Public, Subsidiary
- Established
- 2010-01-01
- Employees
- 172
- Market Cap
- $205.4M
- Website
- http://inhibrx.com
Cybin Corp
๐จ๐ฆCanada
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $202.4M
- Website
- -
